SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-062257
Filing Date
2024-05-16
Accepted
2024-05-16 07:05:52
Documents
13
Period of Report
2024-05-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2414591d1_8k.htm   iXBRL 8-K 25717
  Complete submission text file 0001104659-24-062257.txt   197418

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vygr-20240516.xsd EX-101.SCH 3048
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20240516_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20240516_pre.xml EX-101.PRE 22381
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2414591d1_8k_htm.xml XML 3558
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 24953546
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)